These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4216552)

  • 41. Bromsulphalein movement in decompensated portal cirrhosis.
    MONROE LS; KITTINGER A
    J Lab Clin Med; 1959 Jun; 53(6):901-5. PubMed ID: 13665134
    [No Abstract]   [Full Text] [Related]  

  • 42. [COMPLICATIONS DURING BROMSULPHALEIN TESTS].
    BREGADZE IL; KUZNETSOV IuV
    Klin Med (Mosk); 1964 Jan; 42():117-9. PubMed ID: 14150078
    [No Abstract]   [Full Text] [Related]  

  • 43. [Significance of lipoprotein-X and serum cholinesterase in preoperative diagnosis of obstructive jaundice].
    Prexl HJ; Petek W
    Chirurg; 1973 Jul; 44(7):310-3. PubMed ID: 4353807
    [No Abstract]   [Full Text] [Related]  

  • 44. Factors influencing bromsulphalein retention and its evaluation in bilharzial hepatic fibrosis.
    BADAWI HS; NOMEIR AM; ZAHER RA
    Gut; 1962 Dec; 3(4):318-21. PubMed ID: 13965998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum cholinesterase activity and its diagnostic and prognostic significance in patients with chronic cardiac failure.
    Zydowicz L
    Pol Med J; 1970; 9(2):309-14. PubMed ID: 5422799
    [No Abstract]   [Full Text] [Related]  

  • 46. [DIAGNOSTIC VALUE OF THE COUPLED BROMSULPHALEIN-INDOCYANIN GREEN TEST IN HEPATO-BILIARY PATHOLOGY].
    LEMONNIER F; JULIEN C; CHEVREL B; CAROLI J
    Pathol Biol; 1963 Dec; 11():1362-72. PubMed ID: 14115977
    [No Abstract]   [Full Text] [Related]  

  • 47. [Oral galactose tolerance test in liver diseases. Studies on technics and on the evaluation of results].
    Hennecke A; König KJ; Südhof H
    Dtsch Med Wochenschr; 1972 Jan; 97(4):109-14 passim. PubMed ID: 5008209
    [No Abstract]   [Full Text] [Related]  

  • 48. [Graphic analysis and mathematic model of blood clearance curves of bromsulphalein: the hepatic fixation PF gradient].
    Toulet J; Pagniez R
    Rev Int Hepatol; 1968; 18(4):537-64. PubMed ID: 5688212
    [No Abstract]   [Full Text] [Related]  

  • 49. [Liver function studies with 131-I-bromsulphalein (author's transl)].
    Strötges MW; Nehen HG; Heissen E
    Leber Magen Darm; 1973 Dec; 3(6):257-60. PubMed ID: 4785772
    [No Abstract]   [Full Text] [Related]  

  • 50. Alteration of serum cholinesterase isozyme in patients with liver cirrhosis.
    Hada T; Ohue T; Imanishi H; Nakaoka H; Hirosaki A; Fujikura M; Amuro Y; Higashino K
    Clin Chim Acta; 1988 Nov; 178(1):111-2. PubMed ID: 3228980
    [No Abstract]   [Full Text] [Related]  

  • 51. [ON LIVER FUNCTION TESTS].
    HAYASHI Y
    Chiryo; 1963 Nov; 45():2071-6. PubMed ID: 14096777
    [No Abstract]   [Full Text] [Related]  

  • 52. [On the value of galactose tolerance test in the enzymatic determination of blood galactose level].
    Mehnert H; Haslbeck M; Förster H
    Dtsch Med Wochenschr; 1968 Oct; 93(40):1899-905. PubMed ID: 5679122
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clearance of bromsulphalein in chronic hepatitis. Anatomo-functional study in 104 cases].
    Testa R; Ciravegna G; Dodero M; Celle G
    Recenti Prog Med; 1978 Aug; 65(2):117-21. PubMed ID: 715300
    [No Abstract]   [Full Text] [Related]  

  • 54. [Diagnosis of altered patency of the extrahepatic bile ducts and differentiation of parenchymatous liver lesions by means of bromsulphalein test with duodenal intubation].
    FRIC P; MALIS F; KECLIK M; ZEMAN J
    Cas Lek Cesk; 1962 Sep; 101():1154-8. PubMed ID: 13959690
    [No Abstract]   [Full Text] [Related]  

  • 55. Abnormalities of serum cholinesterase isozyme in liver cirrhosis and hepatoma (Part II).
    Matsuzaki S; Iwamura K; Itakura M; Katsunuma T
    Gastroenterol Jpn; 1980; 15(6):543-9. PubMed ID: 6256250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Galactose elimination capacity, a reliable test for quantitative comprehension of the liver function].
    Heri M; Bircher J
    Schweiz Med Wochenschr; 1971 May; 101(20):735-6. PubMed ID: 5578402
    [No Abstract]   [Full Text] [Related]  

  • 57. [Differential diagnosis: liver cirrhosis or chronic hepatitis. Effect of chronic hepatitis and liver cirrhosis on the retention of bromsulphalein in the blood serum].
    Vido I; Wildhirt E
    Munch Med Wochenschr; 1969 Jan; 111(4):177-80. PubMed ID: 5818553
    [No Abstract]   [Full Text] [Related]  

  • 58. [The oral galactose tolerance as a liver function test. Clinical-experimental studieson the prolem of dosage].
    Rommel K; Grimmel K
    Med Klin; 1967 Feb; 62(5):168-71. PubMed ID: 5590185
    [No Abstract]   [Full Text] [Related]  

  • 59. [Importance in the determination of the serum cholinesterase activity for evaluation of the liver function].
    Straus B; Vasilj L; Plasaj M; Stefanović R; Zadro I; Würth G
    Vojnosanit Pregl; 1975; 32(2):117-20. PubMed ID: 1136258
    [No Abstract]   [Full Text] [Related]  

  • 60. [Serum activity of malate dehydrogenase, alanine and asparagine aminotransferases, non-specific cholinesterase as well as bromsulphalein test in workers exposed to long-term carbon disulfide action].
    Szymañska B
    Ann Acad Med Stetin; 1970; 16():353-73. PubMed ID: 5525977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.